School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou 310053, China; Lishui Academy of Agricultural Sciences, Lishui 323000, China.
School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou 310053, China.
J Ethnopharmacol. 2018 Nov 15;226:143-167. doi: 10.1016/j.jep.2018.08.023. Epub 2018 Aug 18.
Atractylodes macrocephala Koidz. (called Baizhu in China) is a medicinal plant that has long been used as a tonic agent in various ethno-medical systems in East Asia, especially in China, for the treatment of gastrointestinal dysfunction, cancer, osteoporosis, obesity, and fetal irritability.
This review aims to provide a systematic summary on the botany, traditional uses, phytochemistry, pharmacology, pharmacokinetics, and toxicology of A. macrocephala to explore the future therapeutic potential and scientific potential of this plant.
A literature search was performed on A. macrocephala using scientific databases including Web of Science, Google Scholar, Baidu Scholar, Springer, PubMed, SciFinder, and ScienceDirect. Information was also collected from classic books of Chinese herbal medicine, Ph.D. and M.Sc. dissertations, unpublished materials, and local conference papers on toxicology. Plant taxonomy was confirmed to the database "The Plant List" (www.theplantlist.org).
More than 79 chemical compounds have been isolated from A. macrocephala, including sesquiterpenoids, triterpenoids, polyacetylenes, coumarins, phenylpropanoids, flavonoids and flavonoid glycosides, steroids, benzoquinones, and polysaccharides. Crude extracts and pure compounds of A. macrocephala are used to treat gastrointestinal hypofunction, cancer, arthritis, osteoporosis, splenic asthenia, abnormal fetal movement, Alzheimer disease, and obesity. These extracts have various pharmacological effects, including anti-tumor activity, anti-inflammatory activity, anti-aging activity, anti-oxidative activity, anti-osteoporotic activity, neuroprotective activity, and immunomodulatory activity, as well as improving gastrointestinal function and gonadal hormone regulation.
A. macrocephala is a valuable traditional Chinese medicinal herb with multiple pharmacological activities. Pharmacological investigations support the traditional use of A. macrocephala, and may validate the folk medicinal use of A. macrocephala to treat many chronic diseases. The available literature shows that much of the activity of A. macrocephala can be attributed to sesquiterpenoids, polysaccharides and polyacetylenes. However, there is a need to further understand the molecular mechanisms and the structure-function relationship of these constituents, as well as their potential synergistic and antagonistic effects. Further research on the comprehensive evaluation of medicinal quality, the understanding of multi-target network pharmacology of A. macrocephala, as well as its long-term in vivo toxicity and clinical efficacy is recommended.
白术(在中国称为白术)是一种药用植物,长期以来一直被东亚各种民族医学系统用作滋补剂,特别是在中国,用于治疗胃肠道功能障碍、癌症、骨质疏松症、肥胖症和胎儿不安。
本综述旨在对白术的植物学、传统用途、植物化学、药理学、药代动力学和毒理学进行系统总结,以探讨该植物的未来治疗潜力和科学潜力。
使用科学数据库(包括 Web of Science、Google Scholar、百度学术、Springer、PubMed、SciFinder 和 ScienceDirect)对白术进行文献检索。还从中草药经典著作、博士和硕士论文、未发表的材料以及毒理学当地会议论文中收集信息。植物分类学已被确认为数据库“植物名录”(www.theplantlist.org)。
从白术中分离出 79 种以上的化合物,包括倍半萜、三萜、炔烃、香豆素、苯丙素、黄酮类和黄酮苷类、甾体、苯醌和多糖。白术的粗提取物和纯化合物用于治疗胃肠道功能低下、癌症、关节炎、骨质疏松症、脾虚、胎儿异常运动、阿尔茨海默病和肥胖症。这些提取物具有多种药理作用,包括抗肿瘤活性、抗炎活性、抗衰老活性、抗氧化活性、抗骨质疏松活性、神经保护活性和免疫调节活性,以及改善胃肠道功能和性腺激素调节。
白术是一种具有多种药理活性的有价值的中药。药理研究支持白术的传统用途,并可能验证白术民间药用治疗许多慢性疾病的用途。现有文献表明,白术的许多活性可归因于倍半萜、多糖和炔烃。然而,需要进一步了解这些成分的分子机制和结构-功能关系,以及它们的潜在协同和拮抗作用。建议进一步研究白术的药用质量综合评价、白术多靶点网络药理学的认识,以及其长期体内毒性和临床疗效。